Development Center for Biotechnology The Development Centre for Biotechnology was founded in 1984 as a tool for connecting biotechnological academia to the Taiwanese industry and promoting the strengths of Taiwan’s biopharmaceutical sector to the global audience. The centre was established by both government and private industry as a non-profit organization. How do you think…
Abiogen You created Abiogen in 1997, following the acquisition of Istituto Gentili by MSD, in order to maintain your family’s entrepreneurial tradition, keeping building on the legacy of your great-grandfather Commendatore Alfredo Gentili, combining it with your personal innovative vision to create a “new reality”. To have a better understanding of…
LSK Global PS South Korea has a short history of participating in global clinical trials, but now the country is seeing exponential growth in this area. What has changed in recent years leading to this new trend? South Korea has been behind in terms of global clinical trials due to unfriendly regulations, but…
Bioneer Could you provide our international readers with a profile of Bioneer as it stands today? Bioneer, having a strong basis of technology and experiences in molecular biology since 1992, we have optimized various products we offer from oligonucleotides, siRNA, PCR products, the kits, instruments that are necessary from basic scientific…
Zambon You declared in a recent interview that Zambon Group will always keep complying with the vision of your father Alberto, who has always refused acquisition offers from multinationals- a striking approach, in a context of pharmaceutical clusters when so many Italian players have been swallowed by wider structures. Which specific…
Chungcheongbuk-do Although Chungcheongbuk-do is a small province in terms of territory and population, it has gained increasing importance in Korea’s economy. What are the main drivers of this growing economic progression? Chungbcheongbuk-do (Chungbuk) was traditionally an agriculture-based province until its economy started to shift towards more knowledge intensive activities in the…
Bristol-Myers Squibb The pharmaceutical industry in Asia is undergoing a period of specialization with R&D booming in places like Australia, Singapore and South Korea and manufacturing in places like China, India and now Vietnam – how does Indonesia fit into the overall picture? Indonesia has a number of very strong fundamental, macroeconomic…
Depolabo As the market leader in the French pre-wholesale market, Depolado had a quite impressive market share growth in the previous 3 years, now being responsible for a quarter of the French market. As the one responsible for these changes, what was your strategy to further consolidate Depolabo’s leadership in France?…
Biogaran Biogaran was an initiative from Servier in the mid 1990s before there was even a generic pharmaceutical market in France. Could you speak of your history and of the origins of Biogaran and the vision behind starting this company? Biogaran is in line with my previous experience as I was…
Lyonbiopôle As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The biggest differentiating point is that the clusters have been founded on government initiative to create competitive zones across multiple industries.…
Cegedim Deutschland GmbH You joined Cegedim in summer 2006 eleven months before its merger with Dendrite in 2007 that created the world leader in pharmaceutical CRM. How would you describe the integration process of both companies and what were the main synergies between Cegedim and Dendrite in the German context? Germany offered a…
Boehringer Ingelheim France There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these new facilities here at Paris Biopark. What does this express about the moves Boehringer Ingelheim is taking in France and…
See our Cookie Privacy Policy Here
